SSA
LEGN icon

Schonfeld Strategic Advisors’s Legend Biotech LEGN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-99,804
Closed -$4.86M – 2223
2024
Q3 		$4.86M Buy
+99,804
New +$5.32M 0.03% 556
2023
Q4 		– Sell
-14,500
Closed -$974K – 2062
2023
Q3 		$974K Buy
+14,500
New +$1.01M 0.01% 1031
2023
Q2 		– Sell
-7,200
Closed -$347K – 2339
2023
Q1 		$347K Sell
7,200
-6,600
-48% -$323K ﹤0.01% 1312
2022
Q4 		$689K Sell
13,800
-6,700
-33% -$325K 0.01% 1354
2022
Q3 		$836K Sell
20,500
-57,232
-74% -$2.69M 0.01% 1394
2022
Q2 		$4.28M Buy
77,732
+8,798
+13% +$372K 0.04% 516
2022
Q1 		$2.5M Buy
+68,934
New +$2.72M 0.02% 659
2021
Q4 		– Sell
-55,303
Closed -$2.8M – 2360
2021
Q3 		$2.8M Buy
55,303
+29,737
+116% +$1.24M 0.03% 602
2021
Q2 		$1.05M Buy
+25,566
New +$869K 0.01% 916

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Schonfeld Strategic Advisors's LEGN Position: Q4 2024 in Review

Schonfeld Strategic Advisors sold out of Legend Biotech (LEGN) in Q4 2024, closing a stake of 99,804 shares — an estimated $4.86M sold.

Schonfeld Strategic Advisors first reported a position in LEGN in Q2 2021 and held it in 9 quarters. The position peaked at $4.86M in Q3 2024. 211 funds tracked by Wall St. Rank hold LEGN as of Q4 2024.

  • Schonfeld Strategic Advisors reported no remaining Legend Biotech position as of Q4 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 99,804 Legend Biotech shares in Q4 2024, an estimated $4.86M.
  • Schonfeld Strategic Advisors first reported a position in Legend Biotech in Q2 2021 and held it in 9 quarters.
  • Schonfeld Strategic Advisors's Legend Biotech position peaked at $4.86M in Q3 2024.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.